News: $CYAD Celyad Receives Euro8.5 Million in Grants and Non-Dilutive Funding by the Walloon Region
Funding will support the advancement of the Company’s autologous and allogeneic CAR-T cell therapy programs MONT-SAINT-GUIBERT, Belgium, Nov. 22, 2019 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical com...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.